SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RAPEZZI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.426
AS - Asia 7.601
EU - Europa 4.772
SA - Sud America 1.856
AF - Africa 172
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 23.847
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.112
SG - Singapore 3.681
IT - Italia 1.679
BR - Brasile 1.528
CN - Cina 1.364
PL - Polonia 1.180
HK - Hong Kong 1.068
VN - Vietnam 694
DE - Germania 450
ID - Indonesia 322
GB - Regno Unito 312
RU - Federazione Russa 301
FI - Finlandia 203
MX - Messico 197
UA - Ucraina 143
AR - Argentina 129
NL - Olanda 116
SE - Svezia 108
CA - Canada 90
ZA - Sudafrica 88
TR - Turchia 83
IN - India 77
BD - Bangladesh 69
JP - Giappone 63
FR - Francia 60
EC - Ecuador 58
AT - Austria 57
CO - Colombia 39
IQ - Iraq 32
ES - Italia 26
MA - Marocco 22
PK - Pakistan 21
CL - Cile 20
PY - Paraguay 20
VE - Venezuela 20
CH - Svizzera 19
PE - Perù 15
UY - Uruguay 15
LT - Lituania 14
BE - Belgio 13
JO - Giordania 13
EG - Egitto 12
SA - Arabia Saudita 12
AU - Australia 11
CZ - Repubblica Ceca 11
IE - Irlanda 11
TN - Tunisia 11
BO - Bolivia 10
NP - Nepal 10
AZ - Azerbaigian 9
IR - Iran 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
KZ - Kazakistan 8
MY - Malesia 8
UZ - Uzbekistan 8
BG - Bulgaria 7
KE - Kenya 7
PT - Portogallo 7
DZ - Algeria 6
AL - Albania 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
GR - Grecia 5
HN - Honduras 5
KR - Corea 5
LB - Libano 5
MD - Moldavia 5
NG - Nigeria 5
RS - Serbia 5
SN - Senegal 5
TW - Taiwan 5
IL - Israele 4
LY - Libia 4
NZ - Nuova Zelanda 4
CY - Cipro 3
EE - Estonia 3
GT - Guatemala 3
HR - Croazia 3
JM - Giamaica 3
NI - Nicaragua 3
PH - Filippine 3
AM - Armenia 2
AO - Angola 2
BN - Brunei Darussalam 2
BQ - ???statistics.table.value.countryCode.BQ??? 2
BW - Botswana 2
CG - Congo 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
LU - Lussemburgo 2
LV - Lettonia 2
OM - Oman 2
PA - Panama 2
Totale 23.824
Salva come PNG Salva come JPEG
Città #
Singapore 1.765
Warsaw 1.169
Hong Kong 1.062
Ashburn 1.030
Fairfield 1.009
Santa Clara 883
Beijing 685
Woodbridge 540
Houston 456
Wilmington 418
Seattle 370
Cambridge 338
Chandler 335
Princeton 308
Jakarta 283
Ho Chi Minh City 217
Ann Arbor 189
Dallas 163
Milan 151
Los Angeles 150
New York 147
Mexico City 144
Moscow 141
San Diego 137
Munich 136
Rome 136
São Paulo 121
Chicago 115
Hanoi 113
Helsinki 108
Jacksonville 105
London 100
Dong Ket 93
Shanghai 82
Nuremberg 76
Bologna 60
Ferrara 57
Turku 56
Rio de Janeiro 53
Falls Church 51
Naples 48
Tianjin 43
Florence 41
Tokyo 41
Belo Horizonte 36
Brooklyn 32
Izmir 32
Palermo 32
Stockholm 32
Haiphong 31
Redwood City 31
Bremen 30
Johannesburg 30
Nanjing 30
Montreal 29
Buffalo 27
Denver 27
Brasília 26
Norwalk 26
Salt Lake City 26
Bari 24
Boardman 24
Chennai 23
Frankfurt am Main 23
Orem 23
Phoenix 22
Toronto 22
Poplar 21
Boston 20
Curitiba 20
Da Nang 20
Mountain View 20
Quito 20
Campinas 19
Lappeenranta 19
Vienna 19
Guayaquil 18
Hải Dương 18
Porto Alegre 18
Atlanta 17
Guarulhos 17
Messina 17
Turin 17
Kilburn 16
Manchester 16
Redmond 16
San Francisco 16
Dhaka 15
Guangzhou 15
Salvador 15
Santo André 15
Brescia 14
Buenos Aires 14
Hounslow 14
Verona 14
Amman 13
Baghdad 13
Düsseldorf 13
Elk Grove Village 13
Hefei 13
Totale 14.908
Salva come PNG Salva come JPEG
Nome #
Documento di consenso ANMCO/SIC sulla gestione delle miocarditi 789
Linee guida ESC 2015 per il trattamento dell'endocardite infettiva: Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC): Con il patrocinio dell'Associazione Europea di Chirurgia Cardiotoracica (EACTS) e dell'Associazione Europea di Medicina Nucleare (EANM) 400
POPDC1S201F causes muscular dystrophy and arrhythmia by affecting protein trafficking 383
Heart failure with preserved ejection fraction: uncertainties and dilemmas 193
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 191
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 184
Defining the Diagnosis in Echocardiographically Suspected Senile Systemic Amyloidosis 178
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction 175
Gender-related risk of myocardial involvement in systemic amyloidosis 171
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 171
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure 160
Long-term safety of drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis 158
La diagnosi elettrocardiografica di infarto miocardico acuto nell'era dell'angioplastica primaria e delle reti hub and spoke 153
Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis 152
Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role 149
Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study 149
Treatment of cardiac transthyretin amyloidosis: An update 148
COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? 141
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response 140
ARNIs: balancing “the good and the bad” of neuroendocrine response to HF 140
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies? 139
Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study 139
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 139
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 134
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types 133
Functional characterization of two novel mutations in scn5a associated with brugada syndrome identified in Italian patients 131
Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis 127
Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy 125
The Mediterranean diet: a cultural journey 124
A targeted proteomics approach to amyloidosis typing 124
'Corona' versus 'coronary' 122
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study 122
Broadening the Phenotypic Spectrum and the Diagnostic Needs of TTR-Related Cardiac Amyloidosis 121
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis 119
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies 118
Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients 118
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 116
2019 CORONAVIRUS: What are the implications for cardiology? 116
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 115
Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA) 115
Cardiopulmonary exercise testing predicts prognosis in amyloid cardiomyopathy: a systematic review and meta-analysis 114
The Residual Risk of Cerebral Embolism after Carotid Stenting: The Complex Interplay between Stent Coverage and Aortic Arch Atherosclerosis 114
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: A systematic review and meta-analysis 114
The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification 114
Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes 113
Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome - Results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) study 110
Assessment of patients with hereditary transthyretin amyloidosis–understanding the impact of management and disease progression 109
Left ventricular myocardial noncompaction with advanced atrioventricular conduction disorder and ventricular arrhythmias in a young patient: Role of MIB1 gene 109
Looking for a tailored therapy for heart failure: Are we capable of treating the patient instead of the disease? 109
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients with Coronary Stent: How Important Is the Interplay between Stent Type and Time from Stenting to Surgery? 108
Predictors of atrial fibrillation in hypertrophic cardiomyopathy 108
Current evidence on the diagnostic and prognostic role of native T1 mapping in heart diseases 108
A Pathogenic Galactosidase A Mutation Coexisting With an MYBPC3 Mutation in a Female Patient With Hypertrophic Cardiomyopathy 107
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis 104
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 103
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice 103
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 102
Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management 101
Long-term Follow up of Patients with Acute Aortic Syndromes: Relevance of both Aortic and Non-aortic Events 100
Myocarditis in COVID-19 patients: current problems 100
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 100
Standard ecg in brugada syndrome as a marker of prognosis: From risk stratification to pathophysiological insights 100
Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications 100
Cardiac Calcifications: Phenotypes, Mechanisms, Clinical and Prognostic Implications 99
Left atrial structure and function in cardiac amyloidosis 99
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis 99
European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology 98
One year on: The impact of COVID-19 on clinical research 98
Adapting to survive 97
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial) 96
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 95
Clinical use of doppler echocardiography in organic mitral regurgitation: From diagnosis to patients’ management 95
Atrial Flutter in Patient With Critical COVID-19: Beneficial Effects of Rhythm Control on Respiratory Distress 95
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 94
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 94
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 93
Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy 93
State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis 92
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 92
Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index 91
Cardiac amyloidosis: the great pretender 91
Phenotypic heterogeneity of COVID-19 pneumonia: clinical and pathophysiological relevance of the vascular phenotypea 91
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 90
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy 90
The complex interplay between systolic and diastolic function at rest and during exercise in heart failure: the case of cardiac amyloidosis 90
Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics 90
Performance of Synthetic Extracellular Volume Fraction in Different Cardiac Phenotypes From a Prospective Cohort of Patients Referred for Cardiac Magnetic Resonance 90
Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man 90
Neurological involvement in Ile68Leu (p.Ile88Leu) ATTR amyloidosis: not only a cardiogenic mutation 90
The battle against COVID-19: Mortality in Italy 90
IMPLICAZIONI PRATICHE E NUOVI SCENARI DI PROTEZIONE CARDIOVASCOLARE 90
Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review 89
null 89
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: An individual patient data pairwise and network meta-analysis 89
99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis 89
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey) 88
Risk Scores for Cardiac Implantable Electronic Device Infection: Which One to Believe In? 87
Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy 87
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths 87
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization 87
Totale 12.676
Salva come PNG Salva come JPEG
Categoria #
all - tutte 196.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.243
Totale 197.321
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.993 0 0 0 0 0 335 235 335 235 423 195 235
2021/20221.975 133 87 52 33 73 136 188 188 106 197 209 573
2022/20231.696 323 42 120 92 152 186 124 137 179 86 159 96
2023/20241.368 79 130 74 64 114 122 74 85 49 60 68 449
2024/20256.241 220 88 616 193 650 503 204 184 988 1.227 769 599
2025/20267.999 1.180 712 1.556 2.280 2.083 188 0 0 0 0 0 0
Totale 24.634